Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 335

1.

Diffusion-weighted imaging (DWI) of the spleen in patients with liver cirrhosis and portal hypertension.

Klasen J, Lanzman RS, Wittsack HJ, Kircheis G, Schek J, Quentin M, Antoch G, Häussinger D, Blondin D.

Magn Reson Imaging. 2013 Sep;31(7):1092-6. doi: 10.1016/j.mri.2013.01.003. Epub 2013 Jun 2.

PMID:
23731536
2.

Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.

Do RK, Chandarana H, Felker E, Hajdu CH, Babb JS, Kim D, Taouli B.

AJR Am J Roentgenol. 2010 Sep;195(3):671-6. doi: 10.2214/AJR.09.3448. Erratum in: AJR Am J Roentgenol. 2010 Oct;195(4):1043. Chandanara, Hersh [corrected to Chandarana, Hersh].

PMID:
20729445
3.

[Brain conventional MR and DWI in cirrhotic patients:correlated with portal hypertension].

Kong X, Chen H, Luo S, Liang X, Ni L, Qi R, Su Y, Zhang L, Lu G.

Zhonghua Yi Xue Za Zhi. 2014 Aug 26;94(32):2495-500. Chinese.

PMID:
25410919
4.

The effect of liver iron deposition on hepatic apparent diffusion coefficient values in cirrhosis.

Chandarana H, Do RK, Mussi TC, Jensen JH, Hajdu CH, Babb JS, Taouli B.

AJR Am J Roentgenol. 2012 Oct;199(4):803-8.

PMID:
22997371
5.

[Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].

Zhou ML, Yan FH, Xu PJ, Chen CZ, Shen JZ, Li RC, Ji Y, Shi JY.

Zhonghua Yi Xue Za Zhi. 2009 Jul 7;89(25):1757-61. Chinese.

PMID:
19862980
6.

Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.

J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.

PMID:
20657216
7.

The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis.

Cece H, Ercan A, Yıldız S, Karakas E, Karakas O, Boyacı FN, Aydogan T, Karakas EY, Cullu N, Ulas T.

Eur J Radiol. 2013 Aug;82(8):e307-12. doi: 10.1016/j.ejrad.2013.02.022. Epub 2013 Mar 19.

PMID:
23518145
8.

Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron.

Bülow R, Mensel B, Meffert P, Hernando D, Evert M, Kühn JP.

Eur Radiol. 2013 May;23(5):1281-7. doi: 10.1007/s00330-012-2700-2. Epub 2012 Nov 9.

PMID:
23138385
9.

Diffusion-weighted imaging of the liver in patients with chronic liver disease: comparison of monopolar and bipolar diffusion gradients for image quality and lesion detection.

Lewis S, Kamath A, Chatterji M, Patel A, Shyknevsky I, Dyvorne HA, Kuehn B, Taouli B.

AJR Am J Roentgenol. 2015 Jan;204(1):59-68. doi: 10.2214/AJR.13.11695.

PMID:
25539238
10.

Comparison between two-point and four-point methods for quantification of apparent diffusion coefficient of normal liver parenchyma and focal lesions. Value of normalization with spleen.

Papanikolaou N, Gourtsoyianni S, Yarmenitis S, Maris T, Gourtsoyiannis N.

Eur J Radiol. 2010 Feb;73(2):305-9. doi: 10.1016/j.ejrad.2008.10.023. Epub 2008 Dec 16.

PMID:
19091503
11.

Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions.

Taouli B, Sandberg A, Stemmer A, Parikh T, Wong S, Xu J, Lee VS.

J Magn Reson Imaging. 2009 Sep;30(3):561-8. doi: 10.1002/jmri.21876.

PMID:
19711402
12.

Diffusion-weighted imaging (DWI) of the liver in assessing chronic liver disease: effects of the presence and the degree of ascites on ADC values.

Kahraman AS, Kahraman B, Ozdemir ZM, Gormeli CA, Ozdemir F, Dogan M.

Abdom Radiol (NY). 2016 Jan;41(1):56-62. doi: 10.1007/s00261-015-0613-7.

PMID:
26830612
13.

Alveolar echinococcosis of the liver: diffusion-weighted MRI findings and potential role in lesion characterisation.

Becce F, Pomoni A, Uldry E, Halkic N, Yan P, Meuli R, Schmidt S.

Eur J Radiol. 2014 Apr;83(4):625-31. doi: 10.1016/j.ejrad.2013.12.025. Epub 2014 Jan 7.

14.

Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions.

Chiu FY, Jao JC, Chen CY, Liu GC, Jaw TS, Chiou YY, Hsu FO, Hsu JS.

J Comput Assist Tomogr. 2005 Mar-Apr;29(2):176-80.

PMID:
15772533
15.

Diffusion-weighted magnetic resonance imaging of the liver in hepatitis B patients with Child-Pugh a cirrhosis.

Hsu FO, Chiou YY, Chen CY, Liu GC, Chu HC, Liu HC, Chu HM, Hsu JS.

Kaohsiung J Med Sci. 2007 Sep;23(9):442-6.

16.

Prediction of esophageal varices in cirrhotic patients with apparent diffusion coefficient of the spleen.

Razek AA, Massoud SM, Azziz MR, El-Bendary MM, Zalata K, Motawea EM.

Abdom Imaging. 2015 Aug;40(6):1465-9. doi: 10.1007/s00261-015-0391-2.

PMID:
25732406
17.

Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.

Sandrasegaran K, Akisik FM, Lin C, Tahir B, Rajan J, Saxena R, Aisen AM.

AJR Am J Roentgenol. 2009 Dec;193(6):1556-60. doi: 10.2214/AJR.09.2436.

PMID:
19933647
18.

Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.

Wiggermann P, Grützmann R, Weissenböck A, Kamusella P, Dittert DD, Stroszczynski C.

Acta Radiol. 2012 Mar 1;53(2):135-9. doi: 10.1258/ar.2011.100252. Epub 2012 Jan 19.

PMID:
22262868
19.

Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T.

Wang CL, Chea YW, Boll DT, Samei E, Neville AM, Dale BM, Merkle EM.

Eur J Radiol. 2011 Nov;80(2):e1-7. doi: 10.1016/j.ejrad.2010.05.019. Epub 2010 Jun 20.

PMID:
20646887
20.

Diffusion analysis with triexponential function in liver cirrhosis.

Hayashi T, Miyati T, Takahashi J, Fukuzawa K, Sakai H, Tano M, Saitoh S.

J Magn Reson Imaging. 2013 Jul;38(1):148-53. doi: 10.1002/jmri.23966. Epub 2012 Dec 12.

PMID:
23239543

Supplemental Content

Support Center